Vance Terry has filed 3 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 20000 shares of ENANTA PHARMACEUTICALS INC ($ENTA) on March 11, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2026 | ENANTA PHARMACEUTICALS INC | $ENTA | Vance Terry | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 29,019,344 | 9999.99% | 0.07% |
| March 13, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Vance Terry | Director | A | Stock Option (right to buy) | 15700 | $0.00 | 15,700.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Vance Terry | Director | A | Stock Option (right to buy) | 15700 | $0.00 | 15,700.0000 | 0 | 9999.99% | 0.00% |